The Peak Nutrition for Metabolic Health (PANaMAH) platform, is one of four priority research platforms in the New Zealand National Science Challenge (NSC) program, investigating metabolic susceptibility and resilience to type 2 diabetes (T2D). Site of lipid deposition has long been associated with modulation of metabolic risk. In adults with low body mass index (BMI) and total adiposity, the thin on the outside fat on the inside ‘TOFI’ profile may predispose to poor glycaemic control and increased risk of T2D. Characterised by ectopic lipid storage at key sites, purported to be due in part to lipid overspill from safer peripheral stores1, growing evidence shows Asian adults to be at particular risk compared to gender and age matched Caucasian counterparts. High levels of visceral fat has also been associated with decreased peripheral insulin sensitivity and increased hepatic insulin resistance, and can be predictive of fat accumulation in liver and pancreas2. Whilst total body, abdominal and visceral adiposity can be accurately measured using dual energy x-ray absorptiometry (DXA)3, magnetic resonance imaging (MRI) and spectroscopy (MRS) are required to quantify ectopic lipid2,4. However there is a paucity of data that assesses the relationship between fat content of abdominal and visceral compartments measured by the two methodologies. In a cohort of 70 healthy and prediabetic, lean and overweight, Asian Chinese and Caucasian women (aged 44.7 ± 14.3; BMI 27 ± 4.3 kg/m2), abdominal and visceral fat/adiposity from DeXA, (fat mass) and 3 Tesla Chemical shift MRI (fat volume) was compared. Furthermore the impact and quantitative role of visceral fat on indices of glycaemia (fasting plasma glucose, FPG; glycated haemoglobin, HbA1c) was determined.